Individual differences |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |
In the field of neurochemistry, 5-HT receptors are receptors for the neurotransmitter and peripheral signal mediator serotonin, also known as 5-hydroxytryptamine or 5-HT. 5-HT receptors are located on the cell membrane of nerve cells and other cell types including smooth muscle in animals, and mediate the effects of serotonin as the endogenous ligand and of a broad range of pharmaceutical and hallucinogenic drugs. 5-HT receptors effect the release and activity of other neurotransmitters such as glutamate, dopamine and GABA. 5-HT2A receptors increase the activity of glutamate in many areas of the brain, while some other serotonin receptors have the effect of suppressing glutamate. Increased stimulation of 5-HT2A receptors seem to oppose the therapeutic actions of increased stimulation of other serotonin receptors in anti-depressant and anxiolytic treatments. 
With the exception of the 5-HT3 receptor, a ligand gated ion channel, all other 5-HT receptors are G protein coupled seven transmembrane (or heptahelical) receptors that activate an intracellular second messenger cascade.
|5-HT1||Gi/Go coupled||decreasing cellular levels of cAMP|
|5-HT2||Gq/G11 coupled||increasing cellular levels of inositol trisphosphate (IP3) and diacylglycerol (DAG)|
|5-HT3||ligand-gated Na+ and K+ cation channel||depolarizing plasma membrane|
|5-HT4||Gs coupled||increasing cellular levels of cAMP|
|5-HT5A||G protein coupled; the primary coupling appears to be through Gi/o||inhibiting adenylate cyclase activity.|
|5-HT7||Gs coupled||increasing cellular levels of cAMP|
Within these general classes of 5-HT receptors, a number of specific types have been characterized:
Note that there is no 5-HT1C receptor since, after the receptor was cloned and further characterized, it was found to have more in common with the 5-HT2 family of receptors and was redesignated as the 5-HT2C receptor.
References & BibliographyEdit
- ↑ Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 46 (2): 157–203.
- ↑ 2.0 2.1 Nelson DL (2004). 5-HT5 receptors. Current drug targets. CNS and neurological disorders 3 (1): 53–8.
- ↑ Glennon RA, Hong SS, Dukat M, Teitler M, Davis K (1994). 5-(Nonyloxy)tryptamine: a novel high-affinity 5-HT1D beta serotonin receptor agonist. J. Med. Chem. 37 (18): 2828–30.
- ↑ Rang, H. P. (2003). Pharmacology, Edinburgh: Churchill Livingstone. Page 187
- ↑ Target Schizophrenia - Possible future developments. URL accessed on 2007-07-06.
- IUPHAR GPCR Database - 5-HT Receptors
- Serotonin Receptor Subtypes and Ligands by R.A. Glennon, 2000
- G Protein-Coupled Receptor Activation of 5-HT2A and other GPCRs. A hypothetical model of how these receptors work by L.A. Rubenstein, 1997
- Basic Neurochemistry - Serotonin Receptors (published 1999)
- Wesołowska A (2002). In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors. Polish journal of pharmacology 54 (4): 327-41.
- MeSH Serotonin+Receptors
Ion channel, receptor: ligand-gated ion channels
5-HT receptor (5-HT3 serotonin receptor (A)) - GABA receptor (GABA A (α1, α2, α3, α4, α5, α6, β1, β2, β3, γ2, γ3, ε), GABA C (ρ1, ρ2)) - Glycine receptor (α1, α2, β) - Nicotinic acetylcholine receptor (α1, α2, α3, α4, α5, α7, α9, β1, β2, β3, β4, δ, ε, (α4)2(β2)3, (α7)5, Ganglion type, Muscle type)
|Ionotropic glutamate receptors|
|This page uses Creative Commons Licensed content from Wikipedia (view authors).|